[2] [3] Additional important safety considerations include risk of pancreatitis (discontinue if suspected), gallbladder disease, acute kidney injury from dehydration during severe gastrointestinal adverse events, and potential diabetic retinopathy complications in patients with a history of retinopathy
Weight Loss and Fat Reduction Excess fat, particularly visceral fat (fat around the organs), is a major contributor to insulin resistance
long-term discontinuation data are still emerging from Phase 3 TRIUMPH trials
At Body Works in Franklin, TN and Nolensville, TN , physicians prescribe both semaglutide and tirzepatide and tailor the selection to each patient
Patent estate includes the Roche structure patent agreement ($100M upfront, Jan 2026)